Aprezo(Otezla)Apremilast 30mg online


In stock


AprezoOtezla30mg, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of:

1.Adult patients with active psoriatic arthritis

2.Patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy


To reduce risk of gastrointestinal symptoms, titrate to recommended dose of 30 mg twice daily according to the following schedule

Day 1: 10 mg in morning

Day 2: 10 mg in morning and 10 mg in evening

Day 3: 10 mg in morning and 20 mg in evening

Day 4: 20 mg in morning and 20 mg in evening

Day 5: 20 mg in morning and 30 mg in evening

Day 6 and thereafter: 30 mg twice daily

Dosage in Severe Renal Impairment:

Recommended dose is 30 mg once daily

For initial dosage titration, titrate using only morning schedule listed in Table 1 and skip afternoon doses

Aprezo’s brand name is Otezla® by Celgene. Aprezo is a generic oncologic prescription medicine from Glenmark, which is the biggest pharmaceutical company in India.

For more Prescribing information,please check the → “FDA Prescribing Information”

80.00 per 30 Tablets

Submit your review

Your email address will not be published. Required fields are marked *


There are no reviews yet.

See It Styled On Instagram

    Instagram did not return any images.

Main Menu